Home » Topics » BioWorld Science

BioWorld Science
RSS

Orion Biotechnology earns grant to support development of microbicide candidate

July 19, 2018

Selective PDE4D PET ligands developed to study depression and cognitive impairment

July 19, 2018

THX-160 shows promise in preclinical studies for acute and chronic pain

July 19, 2018

SOM Biotech initiates phase IIa trial of repurposed drug

July 19, 2018

Immunity is for babies

July 19, 2018

TAS-05567 selectively inhibits Syk kinase: potential treatment for autoimmune and allergic diseases

July 19, 2018

MANF rescues dopaminergic neurons in C. elegans alpha-synuclein models of Parkinson's disease

July 19, 2018

Fighting senescence boosts immunity

July 19, 2018

Merck & Co. divulges FFA1 receptor agonists

July 18, 2018

Oligomerix presents tau aggregation inhibitors

July 18, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026